Legal status · United States
Is Tesamorelin legal in the United States?
Yes. Tesamorelin is an approved medicine in the United States, classified as "FDA-approved for a specific indication, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Tesamorelin in the United States at a glance
| Classification | FDA-approved for a specific indication, prescription only |
|---|---|
| FDA approval status | FDA-approved (Egrifta) for HIV-associated lipodystrophy |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Tesamorelin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Tesamorelin for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Tesamorelin is
An FDA-approved GHRH analogue that reduces visceral fat, now also studied for cognition in older adults at Alzheimer's risk.
Tesamorelin is a stabilized synthetic GHRH analogue approved for HIV-associated lipodystrophy, where it reduces visceral adipose tissue. It preserves the normal pulsatile pattern of GH release.
Mechanism: Activates pituitary GHRH receptors to stimulate physiological, pulsatile growth hormone release, preserving hypothalamic feedback.
Regulatory history: FDA-approved (Egrifta) for HIV-associated lipodystrophy
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Tesamorelin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Tesamorelin in other countries
United Kingdom
Approved medicineLimited licensing; prescription only
Is Tesamorelin legal in the United Kingdom?Australia
Prescription routePrescription only where available
Is Tesamorelin legal in Australia?Canada
Approved medicineHealth Canada approved (Egrifta), prescription only
Is Tesamorelin legal in Canada?Frequently asked questions
Is Tesamorelin legal in the United States?
Yes. Tesamorelin is an approved medicine in the United States, classified as "FDA-approved for a specific indication, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Tesamorelin in the United States?
Only with a prescription. Tesamorelin is classified as "FDA-approved for a specific indication, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Tesamorelin FDA approved?
Yes. FDA status: FDA-approved (Egrifta) for HIV-associated lipodystrophy. Current US classification: "FDA-approved for a specific indication, prescription only". Evidence level: Strong.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Tesamorelin live on its compound profile.
Tesamorelin profileThis page is general information about the regulatory status of Tesamorelin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.